Quick Answer
ANAPTYSBIO, INC reported Revenue (ASC 606) of $234.60 million for fiscal year 2025.
ANAPTYSBIO, INC Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $234.60M | +157.0% |
| 2024 | $91.28M | +432.0% |
| 2023 | $17.16M | +66.8% |
| 2022 | $10.29M | -83.7% |
| 2021 | $63.17M | -15.8% |
| 2020 | $75.00M | +837.5% |
| 2019 | $8.00M | +60.0% |
| 2018 | $5.00M | -50.0% |
| 2017 | $10.00M | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $76.32M | +154.3% | +242.8% |
| June 30, 2025 | $22.26M | +102.9% | -19.8% |
| March 31, 2025 | $27.77M | +286.8% | -7.5% |
| September 30, 2024 | $30.02M | +804.7% | +173.6% |
| June 30, 2024 | $10.97M | +217.1% | +52.8% |
| March 31, 2024 | $7.18M | +422.5% | +116.4% |
| September 30, 2023 | $3.32M | +156.6% | -4.1% |
| June 30, 2023 | $3.46M | +184.5% | +151.8% |
- ANAPTYSBIO, INC showed an increase of +157.0% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2017–2025 period, ANAPTYSBIO, INC’s revenue (asc 606) has grown by 2246.0% (from $10.00 million to $234.60 million).
- The most recent figure is from ANAPTYSBIO, INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: